GenieBiome
NY-based GenieBiome uses microbiome tech to develop treatments for various diseases, including precision medicine.
Founded
2020NY-based GenieBiome uses microbiome tech to develop treatments for various diseases, including precision medicine.
GenieBiome, founded in New York, is a biotechnology company dedicated to leveraging microbiome research to develop innovative treatments for a range of diseases. Their core mission is to revolutionize healthcare through precision medicine, targeting conditions such as gut illnesses, metabolic syndrome, skin irritation, and mental health disorders. GenieBiome's product portfolio includes diagnostic and risk prediction tests, next-generation microbiome precision formulas, and precision medicine solutions.
Notable figures affiliated with GenieBiome include leading scientists and healthcare professionals specializing in microbiome research. The company has attracted significant investment from venture capital firms focused on biotech innovations. Key achievements include the development of cutting-edge diagnostic tools and personalized treatment plans that have shown promising results in clinical trials. GenieBiome's impact is seen in its potential to transform patient care by offering more accurate diagnoses and effective, individualized treatments.
Companies similar to GenieBiome include BiomeSense, MarvelBiome, DermBiont and BrilliantBiome.
GenieBiome was founded in 2020.
GenieBiome's headquarters is located in New York, US.
GenieBiome's most recent funding round was for $11M (USD) in November 2021.
As of Nov 1, 2021, GenieBiome has disclosed funding of $11M (USD). Undisclosed round amounts are excluded.
GenieBiome has 30 employees as of Feb 4, 2024.
BrilliantBiome
brilliantbiome.com
